Ozanezumab
Product Specifications
UNSPSC Description
Ozanezumab (GSK1223249) is an anti-Nogo-A (neurite outgrowth inhibitor A) monoclonal antibody. Ozanezumab can be used in amyotrophic lateral sclerosis (ALS) and multiple sclerosis research[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Neuroscience-Neurodegeneration
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ozanezumab.html
Solubility
10 mM in DMSO
Smiles
[Ozanezumab]
References & Citations
[1]Meininger V, et al. Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2017 Mar;16(3):208-216.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99213/Ozanezumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99213/
Clinical Information
Phase 2
CAS Number
1310680-64-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6464328-01 0.1 mL
AT-rich Interactive Domain-containing Protein 3B, CT (ARID3B, ARID Domain-containing Protein 3B, Bright-like Protein, Bright and Dead Ringer Protein, BDP, DRIL2) (MaxLight 650)
Ask
View Details 
MBS6464328-02 5x 0.1 mL
AT-rich Interactive Domain-containing Protein 3B, CT (ARID3B, ARID Domain-containing Protein 3B, Bright-like Protein, Bright and Dead Ringer Protein, BDP, DRIL2) (MaxLight 650)
Ask
View Details 